Uzara for Period Pain: Four Trial Checks

Who participated?

Sixty students received Uzara root extract and ibuprofen across two cycles in an unblinded crossover trial. Ages were 19–28; 46 had moderate pain and 14 severe pain.¹

What counted as success?

At four hours, 47/60 Uzara cycles versus 52/60 ibuprofen cycles had pain scores ≤3/10, not necessarily zero. No equivalence margin was specified; equal benefit was not established. Pain-curve analyses excluded 17 rescue-medication cycles. No unwanted effects were reported with Uzara versus five gastrointestinal complaints with ibuprofen; this small study cannot establish safety. The attached protocol did not specify the published four-hour success threshold. Authors funded the study and declared no competing interests.¹

Is this a period-pain product?

The September 2019 German tablet information lists acute nonspecific diarrhea, not period pain. Contraindications include pregnancy, breastfeeding, cardiac glycosides and low potassium or magnesium. This dated document cannot establish 2026 availability.²

When should pain be assessed?

NHS³ advice includes heat, gentle exercise and medicines such as ibuprofen. Seek assessment when pain disrupts daily activities. Seek urgent medical help if pain is severe or worse than usual and painkillers have not helped.³

Period, Handled includes “Bringing It to the Appointment.” Record what pain prevents, which treatments you tried, their duration and the number of cycles covered. Bring those notes and questions about further assessment.